Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Ritchie

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Therapeutics|March 24, 2009
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational studyEli N Deal, Scott T Micek, Richard M Reichley, et al.
Pharmacotherapy|October 6, 2004
Enterococcus faecalis resistant to linezolid: case series and review of the literatureBrian S Burleson, David J Ritchie, Scott T Micek, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2021
Evaluation of Total Body Weight versus Adjusted Body Weight Liposomal Amphotericin B Dosing in Obese PatientsMichelle H Ting, Andrej Spec, Scott T Micek, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2011
Acute renal insufficiency during telavancin therapy in clinical practiceLuis A Marcos, Bernard C Camins, David J Ritchie, et al.
Pharmacotherapy|December 25, 2007
Early clinical experience with anidulafungin at a large tertiary care medical centerBenjamin D Brielmaier, Ed Casabar, Christine M Kurtzeborn, et al.
Chest|January 10, 2019
Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial PneumoniaMaren C Cowley, David J Ritchie, Nicholas Hampton, et al.
Infection Control and Hospital Epidemiology|September 9, 2022
Spectrum scores: Toward a better definition of de-escalationDaniel T Ilges, David J Ritchie, Tamara Krekel, et al.
Pharmacotherapy|April 12, 2003
Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literatureBrian J Barnes, Nathan P Wiederhold, Scott T Micek, et al.
Pharmacotherapy|June 28, 2007
Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniaeMichael W Daly, David J Riddle, Nathan A Ledeboer, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
New Perspectives on Antimicrobial Agents: Ceftolozane-TazobactamBryan D Lizza, Kevin D Betthauser, David J Ritchie, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Therapeutics|March 24, 2009
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational studyEli N Deal, Scott T Micek, Richard M Reichley, et al.
Pharmacotherapy|October 6, 2004
Enterococcus faecalis resistant to linezolid: case series and review of the literatureBrian S Burleson, David J Ritchie, Scott T Micek, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2021
Evaluation of Total Body Weight versus Adjusted Body Weight Liposomal Amphotericin B Dosing in Obese PatientsMichelle H Ting, Andrej Spec, Scott T Micek, et al.
The Journal of Antimicrobial Chemotherapy|December 17, 2011
Acute renal insufficiency during telavancin therapy in clinical practiceLuis A Marcos, Bernard C Camins, David J Ritchie, et al.
Pharmacotherapy|December 25, 2007
Early clinical experience with anidulafungin at a large tertiary care medical centerBenjamin D Brielmaier, Ed Casabar, Christine M Kurtzeborn, et al.
Chest|January 10, 2019
Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial PneumoniaMaren C Cowley, David J Ritchie, Nicholas Hampton, et al.
Infection Control and Hospital Epidemiology|September 9, 2022
Spectrum scores: Toward a better definition of de-escalationDaniel T Ilges, David J Ritchie, Tamara Krekel, et al.
Pharmacotherapy|April 12, 2003
Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literatureBrian J Barnes, Nathan P Wiederhold, Scott T Micek, et al.
Pharmacotherapy|June 28, 2007
Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniaeMichael W Daly, David J Riddle, Nathan A Ledeboer, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
New Perspectives on Antimicrobial Agents: Ceftolozane-TazobactamBryan D Lizza, Kevin D Betthauser, David J Ritchie, et al.
Pageof 4